erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."
.
.
.
"we were quite surprised to find there were no significant differences," says study author
.previous efforts to treat babies with the same protein shortly after birth had failed, schneider said.
https://grassfed.us/Abadie-grandma-of-Cockrel-from-Xaltocan
.
.